Protein Synthesis Inhibitors Flashcards
Classes of antibacterial protein synthesis inhhibtors
- macrolides
- tetracyclines
- aminglycosides
- lincomycins (clindamycin)
- oxazolidinones
- streptogamins
- chloramphenicol
Macrolides: examples
- erythromycin
- clarithromycin
- azithromycin
Macrolides: mechanism of action
- blocks protein synthesis
- binds 50S ribosomal subunit and blocks translocation
- bacteriostatic
Macrolides: pharmocokinetics
- good oral –> can be absorbed in GI tract
- wide distribution except to brain/CSF
- metabolism involves both liver and kidney
Macrolides: spectrum/clinical use
- gram+ cocci/rods (strep, staph, pneumococci)
- some gram- cocci
- gram- bacilli (pertussis, H. flu, H. pylori)
- atypical: mycoplasma/chlamydia
Macrolides: adverse reactions
- GI disturbances
- some drug interactions possible
Tetracyclines: examples
- tetracycline
- doxycycline
- minocycline
Tetracyclines: mechanism of action
- protein synthesis inhibitor
- bacteriostatic
- binds 30S ribosome
Tetracyclines: pharmacokinetics
- good oral (on empty stomach, impaired by milk)
- excellent tissue penetration
- concentrated in liver, most excreted in urine (except doxy/mino)
Tetracyclines: spectrum/clinical uses
- broad spectrum agent (many organisms now resistant)
- gram+ cocci (MRSA)
- atypical organisms: chlamydia, mycoplasma
- spirochetes
Tetracyclines: adverse reaction
- avoid during 2nd half of pregnancy and children < 8yo
- GI disturbance
- yeast infection
- drug interaction w/antacids and iron supplements –> decreased bioavailability
Clindamycin: mechanism of action
- inhibit protein synthesis
- binding 50S subunit
- bacteriostatic
Clindamycin: pharmacokinetics
- good oral
- penetrates most tissue well, especially bone (not CSF)
- liver metabolism
- excreted in breast milk
Clindamycin: spectrum/clinical uses
- treatment of severe anaerobic infections
- narrow spectrum
- gram+ cocci (strep, MSSA osteomyelitis, MRSA cutaneous)
- anaerobes (bacteroides fragilis)
Clindamycin: adverse reactions
- pseudomembranous colitis
- severe diarrhea
Aminglycosides: examples
- streptomycin
- tobramycin
- gentamicin
Aminglycosides: mechanism of action
- protein synthesis inhibitor
- bactericidal
- inhibits protein synthesis initiation
Aminglycosides: pharmacokinetics
- poor oral, good IV or IM
- distributes only to ECF
- renal excretion
Aminglycosides: spectrum/clinical uses
- limited by toxicity
- narrow spectrum
- gram- bacilli aerobes (pseudomonoas, E. coli)
Aminglycosides: adverse reactions
- very toxic
- eighth nerve damage (auditory, vestibular)
- reversible renal toxicity
- drug-drug interactions w/B-lactams (enhance) and penicilinns (inhibit)
Chloramphenicol: mechanism of actions
- inhibit protein synthesis
- binding to 50S ribosome
- mostly bacteriostatic
Chloramphenicol: pharmacokinetics
- good oral
- widely distributed, including CNS/CSF
- liver metabolism
- excreted in breast milk
Chloramphenicol: spectrum/clinical uses
- broad spectrum (limited by toxicity)
- gram+/- cocci (N. meningitis)
- gram- bacilli (H. flu, salmonella typhi=typhoid fever)
- anaerobes (bacteroides)
- atypical organisms (rickettsia)
Chloramphenicol: adverse reactions
- bone marrow toxicity
- gray baby syndrome
- GI disturbances
Oxazolidinone (Linezolid): mechanism of action
- novel protein synthesis inhibitor
- bacteriostatic
- binds 50S ribosome
Oxazolidinone (Linezolid): pharmacokinetics
- good oral (IV available)
- readily distributed to well-perfused tissue
- nonenzymatic metabolism; some renal excretion
Oxazolidinone (Linezolid): spectrum/clinical uses
- used for life-threatening infections
- gram+ cocci: enterococci (+VRE), staphylococci (+MRSA), streptococci
Oxazolidinone (Linezolid): adverse reactions
- minor
- inhibits MAO; linezolid+SSRI–>hypertensive response
Streptogramin (Quinupristin/Dalfopristin): mechanism of action
- protein synthesis inhibitor
- binds 50S ribosome
- bactericidal
Streptogramin (Quinupristin/Dalfopristin): pharmacokinetics
- IV only
- liver metabolism + biliary excretion (no renal)
Streptogramin (Quinupristin/Dalfopristin): spectrum/clinical uses
- used for life-threatening infections
- gram+ cocci: enterococci (+VRE), staphylococci (+MRSA), streptococci
Streptogramin (Quinupristin/Dalfopristin): adverse reactions
- infusion site irritation
- inhibits CYP3A4 –> increase plasma levels of drugs metabolized by that enzyme